These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 480153)

  • 21. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation.
    Dong Z; Chatterji A; Sandhu H; Choi DS; Chokshi H; Shah N
    Int J Pharm; 2008 May; 355(1-2):141-9. PubMed ID: 18243605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid state characterization of E2101, a novel antispastic drug.
    Kushida I; Ashizawa K
    J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons.
    Chokshi RJ; Zia H; Sandhu HK; Shah NH; Malick WA
    Drug Deliv; 2007 Jan; 14(1):33-45. PubMed ID: 17107929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Paluch KJ; Tajber L; Grembecka M; Hawelek L; Wojnarowska Z; Grzybowska K; Talik E; Paluch M
    Eur J Pharm Sci; 2014 Oct; 62():132-40. PubMed ID: 24907679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical characterization of the hydrates of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1988 May; 77(5):444-51. PubMed ID: 3411469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability study of amorphous valdecoxib.
    Ambike AA; Mahadik KR; Paradkar A
    Int J Pharm; 2004 Sep; 282(1-2):151-62. PubMed ID: 15336390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying.
    Yonemochi E; Kitahara S; Maeda S; Yamamura S; Oguchi T; Yamamoto K
    Eur J Pharm Sci; 1999 Mar; 7(4):331-8. PubMed ID: 9971917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates.
    Henwood SQ; Liebenberg W; Tiedt LR; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1017-30. PubMed ID: 11794804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
    Won DH; Kim MS; Lee S; Park JS; Hwang SJ
    Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate.
    Liu C; Zhu SJ; Zhou Y; Wei YP; Pei YY
    Pharmazie; 2006 Aug; 61(8):681-4. PubMed ID: 16964710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid phases of tenoxicam.
    Cantera RG; Leza MG; Bachiller CM
    J Pharm Sci; 2002 Oct; 91(10):2240-51. PubMed ID: 12226851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M; Liebenberg W; Aucamp M
    AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid-state characterization of fluconazole.
    Alkhamis KA; Obaidat AA; Nuseirat AF
    Pharm Dev Technol; 2002 Nov; 7(4):491-503. PubMed ID: 12503530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.